Science Explorer Back to mapMap
Discussion
Researcher · University of Pittsburgh · United States

Dario A.A. Vignali

Dario A.A. Vignali publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-2771-5992 OpenAlex
World rank
#9,525
of 7,710,434 ranked researchers
Rank in United States
#3,269
of 1,627,098
Works
451
Citations
53k
Citations per work
117.5
h-index
105
i10-index 233Top 0.3% in Immunology
Dario A.A. Vignali

What does Dario A.A. Vignali research?

Dario A.A. Vignali's work is mostly in Immunology and Microbiology (47%), Medicine (24%), Biochemistry, Genetics and Molecular Biology (13%).

Life Sciences: 272 works · 60.4% of their workImmunology and Microbiology: 212 works · 47.0% of their workImmunology: 212 works · 47.0% of their workBiochemistry, Genetics and Molecular Biology: 60 works · 13.4% of their workMolecular Biology: 37 works · 8.1% of their workGenetics: 16 works · 3.6% of their workCancer Research: 8 works · 1.7% of their workHealth Sciences: 109 works · 24.1% of their workMedicine: 109 works · 24.1% of their workOncology: 101 works · 22.4% of their workPulmonary and Respiratory Medicine: 8 works · 1.7% of their workEverything else: 70 works · 15.5% of their workTHEIR WORKDario A.A.Vignali451works
Life Sciences60%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology21247.0%
    2. Biochemistry, Genetics and Molecular Biology6013.4%
    1. Medicine10924.1%
  3. Everything else7015.5%
  1. 1Immunology47% of their works
  2. 2Oncology22% of their works
  3. 3Molecular Biology8% of their works
  4. 4Genetics4% of their works
  5. 5Cancer Research2% of their works
  6. 6Pulmonary and Respiratory Medicine2% of their works

Research topics

Which keywords describe Dario A.A. Vignali's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Cancer Immunotherapy, Autoimmunity, Foxp3, TGF-ß, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. NK Cell Recognition1921 topic
  2. Natural Killer Cells1921 topic
  3. Cancer Immunotherapy1772 topics
  4. Autoimmunity1712 topics
  5. Foxp31451 topic
  6. TGF-ß1451 topic
  7. Immune Checkpoint Blockade1311 topic
  8. PD-1 and PD-L11311 topic
  9. Dendritic Cells1021 topic
  10. Immunity1021 topic
  11. Immunotherapy1012 topics
  12. CAR T Cells751 topic
  13. Chimeric Antigen Receptor751 topic
  14. Genetics261 topic
  15. Type 1 Diabetes261 topic
  16. Pattern Recognition Receptors161 topic
  17. Single-Cell161 topic
  18. Toll-like Receptors161 topic
  19. Transcriptomics161 topic

Where does Dario A.A. Vignali work?

Dario A.A. Vignali's main affiliation in the publication record is University of Pittsburgh, United States.

How many publications and citations does Dario A.A. Vignali have?

OpenAlex counts 451 works and 53,003 citations for Dario A.A. Vignali, an h-index of 105, ranking #9,525 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dario A.A. Vignali. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.